Graeber M - Search Results

1

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y; Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Wahn U, et al. Among authors: graeber m. Pediatrics. 2002 Jul;110(1 Pt 1):e2. doi: 10.1542/peds.110.1.e2. Pediatrics. 2002. PMID: 12093983 Clinical Trial.

2

Ascomycins: promising agents for the treatment of inflammatory skin diseases.

Paul C, Graeber M, Stuetz A. Paul C, et al. Among authors: graeber m. Expert Opin Investig Drugs. 2000 Jan;9(1):69-77. doi: 10.1517/13543784.9.1.69. Expert Opin Investig Drugs. 2000. PMID: 11060661 Review.

3

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.

Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. Hanifin JM, et al. Among authors: graeber m. Exp Dermatol. 2001 Feb;10(1):11-8. doi: 10.1034/j.1600-0625.2001.100102.x. Exp Dermatol. 2001. PMID: 11168575

4

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis.

Luger T, Van Leent EJ, Graeber M, Hedgecock S, Thurston M, Kandra A, Berth-Jones J, Bjerke J, Christophers E, Knop J, Knulst AC, Morren M, Morris A, Reitamo S, Roed-Petersen J, Schoepf E, Thestrup-Pedersen K, Van Der Valk PG, Bos JD. Luger T, et al. Among authors: graeber m. Br J Dermatol. 2001 Apr;144(4):788-94. doi: 10.1046/j.1365-2133.2001.04134.x. Br J Dermatol. 2001. PMID: 11298538 Clinical Trial.

5

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C, Graeber M. Eichenfield LF, et al. Among authors: graeber m. J Am Acad Dermatol. 2002 Apr;46(4):495-504. doi: 10.1067/mjd.2002.122187. J Am Acad Dermatol. 2002. PMID: 11907497 Clinical Trial.

6

Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.

Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, Pires MC, Cruz PD Jr, Langley RG, Patel P, Bush C, Thurston M, Graeber M, Cherill R; Multicenter Investigator Group. Belsito DV, et al. Among authors: graeber m. Cutis. 2004 Jan;73(1):31-8. Cutis. 2004. PMID: 14964629 Clinical Trial.

7

A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.

Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; Adapalene-BPO Study Group. Gold LS, et al. Among authors: graeber m. Cutis. 2009 Aug;84(2):110-6. Cutis. 2009. PMID: 19746769 Clinical Trial.

8

An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion.

Mrowietz U, Wustlich S, Hoexter G, Graeber M, Bräutigam M, Luger T. Mrowietz U, et al. Among authors: graeber m. Acta Derm Venereol. 2003;83(5):351-3. doi: 10.1080/00015550310003791. Acta Derm Venereol. 2003. PMID: 14609102 Free article. Clinical Trial.

9

The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion.

Mrowietz U, Graeber M, Bräutigam M, Thurston M, Wagenaar A, Weidinger G, Christophers E. Mrowietz U, et al. Among authors: graeber m. Br J Dermatol. 1998 Dec;139(6):992-6. doi: 10.1046/j.1365-2133.1998.02554.x. Br J Dermatol. 1998. PMID: 9990361 Clinical Trial.

10

Long-term safety and efficacy study of adapalene 0.3% gel.

Weiss JS, Thiboutot DM, Hwa J, Liu Y, Graeber M. Weiss JS, et al. Among authors: graeber m. J Drugs Dermatol. 2008 Jun;7(6 Suppl):s24-8. J Drugs Dermatol. 2008. PMID: 18575223 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page